Exclusive

Publication

Byline

Location

Clinical Trial: To Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903506) titled 'To Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Autologous Stem Cell Tr... Read More


Clinical Trial: A Phase 2, Open-Label, Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904767) titled 'A Phase 2, Open-Label, Multicenter Study to Compare Efficacy and Safety of a Novel Topical ... Read More


Clinical Trial: Pancoronavirus Vaccine Study in Healthy Adults Ages 18-55

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902583) titled 'Pancoronavirus Vaccine Study in Healthy Adults Ages 18-55' on Oct. 22. Brief Summary: The ... Read More


Clinical Trial: Effect of Cholecalciferol on Mucin-1 Levels in Urinary Extracelllular Vesicles in Individuals With Autosomal Dominant Tubulo-Interstitial Kidney Disease Due to MUC1 Mutations (ADTKD-MUC1)

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903909) titled 'Effect of Cholecalciferol on Mucin-1 Levels in Urinary Extracelllular Vesicles in Individua... Read More


Clinical Trial: Molecular Evidence of Rejection Intervention Trial

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905599) titled 'Molecular Evidence of Rejection Intervention Trial' on Oct. 21. Brief Summary: MERIT is a ... Read More


DRUG ENFORCEMENT ADMINISTRATION ISSUES RULE: SCHEDULES OF CONTROLLED SUBSTANCES: PLACEMENT OF CENTANAFADINE IN SCHEDULE III

WASHINGTON, Oct. 30 -- Drug Enforcement Administration has issued a rule called: Schedules of Controlled Substances: Placement of Centanafadine in Schedule III. The rule was published in the Federal ... Read More


FOOD AND DRUG ADMINISTRATION ISSUES RULE: MEDICAL DEVICES; RADIOLOGY DEVICES; CLASSIFICATION OF THE RADIOLOGY SOFTWARE FOR REFERRAL OF FINDINGS RELATED TO FIBROTIC LUNG DISEASE

WASHINGTON, Oct. 30 -- Food and Drug Administration has issued a rule called: Medical Devices; Radiology Devices; Classification of the Radiology Software for Referral of Findings Related to Fibrotic ... Read More


FOOD AND DRUG ADMINISTRATION ISSUES RULE: MEDICAL DEVICES; GENERAL AND PLASTIC SURGERY DEVICES; CLASSIFICATION OF THE SOFTWARE-AIDED ADJUNCTIVE DIAGNOSTIC DEVICE FOR USE BY PHYSICIANS ON LESIONS SUSPICIOUS FOR SKIN CANCER

WASHINGTON, Oct. 30 -- Food and Drug Administration has issued a rule called: Medical Devices; General and Plastic Surgery Devices; Classification of the Software-Aided Adjunctive Diagnostic Device fo... Read More


FOOD AND DRUG ADMINISTRATION ISSUES RULE: MEDICAL DEVICES; ANESTHESIOLOGY DEVICES; CLASSIFICATION OF THE OVER-THE-COUNTER DEVICE TO ASSESS RISK OF SLEEP APNEA

WASHINGTON, Oct. 30 -- Food and Drug Administration has issued a rule called: Medical Devices; Anesthesiology Devices; Classification of the Over-the-Counter Device To Assess Risk of Sleep Apnea. The... Read More


FOOD AND DRUG ADMINISTRATION ISSUES RULE: MEDICAL DEVICES; ANESTHESIOLOGY DEVICES; CLASSIFICATION OF THE SPINAL IMAGING SYSTEM FOR NEURAXIAL PROCEDURES

WASHINGTON, Oct. 30 -- Food and Drug Administration has issued a rule called: Medical Devices; Anesthesiology Devices; Classification of the Spinal Imaging System for Neuraxial Procedures. The rule w... Read More